Skip to main content
. 2008 Jan 25;105(4):62–68. doi: 10.3238/arztebl.2008.0062

Table 3. Medicinal treatment options for polycythemia vera (PV).

Active substance Undesirable effects Prospective randomized studies Approved in Germany for treatment of PV
Hydroxyurea Mucosal intolerance, drug fever, skin tumors (spinocellular cancer), leukemogenic activity not ruled out so far Yes Approved
Interferon α Influenza like symptoms, psychiatric side effects or even psychosis No Not approved
Anagrelide Palpitations, diarrhea No Not approved